Cancer incidence in appalachia, 2004-2011

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 2, 2016, Pages 250-258

  Wilson, Reda J ^a   Ryerson, A Blythe ^a   Singh, Simple D ^a   King, Jessica B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CANCER; BLACK PERSON; BREAST CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CAUCASIAN; CHILD; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; ERROR; ETHNIC DIFFERENCE; FEMALE; HUMAN; INFANT; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NEOPLASM; NEWBORN; PHARYNX CANCER; PRIORITY JOURNAL; RECTUM CANCER; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; THYROID CANCER; TOBACCO USE; UNITED STATES; UTERINE CERVIX CANCER; UTERUS CANCER; HISTORY; INCIDENCE; MIDDLE AGED; NEOPLASMS; PRESCHOOL CHILD; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APPALACHIAN REGION; CHILD; CHILD, PRESCHOOL; FEMALE; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 84957804042     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0946     Document Type: Article

References (44)

1. Appalachian Regional Commission [Internet]. Washington, DC. Available from: http://www.arc.gov/index.asp.
2. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER-Stat Database: Populations - Total U.S. (1969-2012) - Linked To County Attributes - Total U.S., 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released December 2013.
3. SEER Stat Database: NPCR and SEER Incidence - Analytic file - 1998-2011 - jbk 082714 - Linked To County Attributes - Total U.S., 1969-2012 Counties.
4. County-Level Data Sets: Poverty.USDAEconomic Research Service. Source: Bureau of theCensus, Small Area Income and Poverty Estimates [cited 2013 Nov. 7]. Available from: http://ers.usda.gov/data-products/county-leveldata-sets/poverty.aspx.
5. Anderson RT, Yang TC, Matthews SA, Camacho F, Kern T, Mackley HB, et al. Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter? Health Serv Res 2014; 49:546-67.
6. Kelly KM, Shedlosky-Shoemaker R, Porter K, Desimone P, Andrykowski M. Cancer recurrence worry, risk perception, and informational-coping styles among Appalachian cancer survivors. J Psychosoc Oncol 2011; 29:1-18.
7. Vanderpool RC, Huang B. Cancer risk perceptions, beliefs, and physician avoidance in Appalachia: results from the 2008 HINTS Survey. J Health Commun 2010;15 Suppl 3:78-91.
8. Behringer B, Krishnan K. Understanding the role of religion in cancer care in Appalachia. South Med J 2011;104:295-6.
9. Linnan LA, Weiner BJ, Bowling JM, Bunger EM. Views about secondhand smoke and smoke-free policies among North Carolina restaurant owners before passage of a law to prohibit smoking. N C Med J 2010; 71:325-33.
10. Schoenberg N, Baltisberger J, Bardach S, Dignan M. Perspectives on pap test follow-up care among rural Appalachian women. Women Health 2010;50:580-97.
11. Horner MJ, Altekruse SF, Zou J, Wideroff L, Katki HA, Stinchcomb D. US geographic distribution of pre-vaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev 2011;20:591-9.
12. Katz ML, Reiter P, Fickle D, Heaner S, Sim C, Lehman A, et al. Community involvement in the development and feedback about a colorectal cancer screening media campaign in Ohio Appalachia. Health Promot Pract 2010;12:589-99.
13. Hall HI, Rogers JD, Weir HK, Miller DS, Uhler RJ. Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976-1996. Cancer 2000;89:1593-602.
14. Armstrong LR, Thompson T, Hall HI, Coughlin SS, Steele B, Rogers JD. Colorectal carcinoma mortality among Appalachian men and women, 1969-1999. Cancer 2004;101:2851-8.
15. Borak J, Salipante-Zaidel C, Slade MD, Fields CA. Mortality disparities in Appalachia reassessment of major risk factors. J Occup Environ Med 2012;54:146-56.
16. Wingo PA, Tucker TC, Jamison PM, Martin H, McLaughlin C, Bayakly R, et al. Cancer in Appalachia, 2001-2003. Cancer 2008;112:181-92.
17. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2011 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014.
18. Lengerich EJ, Tucker TC, Powell RK, Colsher P, Lehman E, Ward AJ, et al. Cancer incidence in Kentucky, Pennsylvania, andWest Virginia: disparities in Appalachia. J Rural Health Winter 2005;21:39-47.
19. Hopenhayn C, Bush H, Christian A, Shelton BJ. Comparative analysis of invasive cervical cancer incidence rates in three Appalachian states. Prev Med 2005;41:859-64.
20. Hendryx M, O'Donnell K, Horn K. Lung cancer mortality is elevated in coalmining areas of Appalachia. Lung Cancer 2008;62:1-7.
21. Appalachian Regional Commission. An analysis of disparities in health status and access to health care in the Appalachian Region. 2007 [cited 2015 Feb. 25]. Available from: http//www.arc.gov/research/researchreportdetails.asp?REPORT-ID82.
22. Appalachia Community Cancer Network. Addressing the cancer burden in Appalachian communities. 2010 [cited 2015 Jan. 21]. Available from: http://www.accnweb.com/pages/cancer-burden-app.pdf.
23. Paskett ED, Fisher JL, Lengerich EJ, Schoenberg NE, Kennedy SK, Conn ME, et al. Disparities in underserved white populations: The case of cancer-related disparities in Appalachia. Oncologist 2011;16: 1072-81.
24. Hall HI, Uhler RJ, Coughlin SS, Miller DS. Breast and cervical cancer screening among Appalachian women. Cancer Epidemiol Biomarkers Prev 2002;11:137-42.
25. American Cancer Society. Cancer facts & figures 2014. Atlanta: American Cancer Society; 2014.
26. Underwood JM, Richards TB, Henley SJ, Momin B, Houston K, Rolle I, et al. Decreasing trend in tobacco-related cancer incidence, United States 2005- 2009. J Community Health 2015;40:414-8.
27. CDC, smoking & tobacco use, office on smoking and health [Internet; cited 2014 Oct. 7]. Available from: http://www.cdc.gov/tobacco/data-statistics/index.htm.
28. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, et al. Annual Report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012;118:2338-66.
29. Recommendations for Primary Care Practice. U.S. Preventive Services Task Force. 2014 [cited 2015 Feb. 5]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Name/recommendations.
30. Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J Rural Health 2004;20:118-24.
31. Dignan M, Shelton B, Slone SA, Tolle C, Mohammad S, Schoenberg N, et al. Effectiveness of a primary care practice intervention for increasing colorectal cancer screening in Appalachian Kentucky. Prev Med 2014; 58:70-4.
32. American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
33. Li J, German R, King J, Joseph D, Thompson T, WuXC, et al. Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiol 2012;36:122-7.
34. Cook MB, Rosenberg PS, McCarty FA, Wu M, King J, Eheman C, et al. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008. Prostate 2015;75:758-63.
35. Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF. On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol 2007;177:1992-9.
36. Faisal FA, Sundi D, Cooper JL, Humphreys EB, Partin AW, Han M, et al. Racial disparities in oncologic outcomes after radical prostatectomy: longterm follow-up. Urology 2014;84:1434-41.
37. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2012.
38. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Task Force recommendation statement. Ann Intern Med 2008;149:185-91.
39. Li J, Berkowitz Z, Richards TB, Richardson LC. Shared decision making in prostate-specific antigen testing with men older than 70 years. J Am Board Fam Med 2013;26:401-8.
40. Moyer VAU.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2012;157:120-34.
41. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2020. JAMA 2006;295:2164-7.
42. Yoo F, Chaikhoutdinov I, Mitzner R, Liao J, Goldenberg D. Characteristics of incidentally discovered thyroid cancer. JAMA Otolaryngol Head Neck Surg 2013;139:1181-6.
43. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014;140:317-22.
44. Malone MK, Zagzag J, Ogilvie JB, Patel KN, Heller KS. Thyroid cancers detected by imaging are not necessarily small or early stage. Thyroid 2014;24:314-8.